ArticleGland surgery2026
Risk factors for postoperative renal function decline after laparoscopic adrenalectomy in patients with primary aldosteronism: a retrospective cohort study.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Renal function decline has been observed in primary aldosteronism (PA) after adrenalectomy. This study aims to evaluate renal function changes after six months post-adrenalectomy and identify predictors of significant estimated glomerular filtration rate (eGFR) decline to aid in risk stratification. Methods: This retrospective cohort study analyzed the medical records of patients with PA who underwent laparoscopic adrenalectomy at King Chulalongkorn Memorial Hospital, Thailand (between 2003 and 2025). Demographic and clinical data, including preoperative and postoperative eGFR, were collected. Renal function decline (eGFR decline) was defined as a ≥25% reduction of eGFR at 6 months postoperative compared with preoperative. Multivariate logistic regression was performed to identify independent predictors of renal function decline. Results: A total of 347 patients were included. After surgery, 251 patients (72.3 %) experienced a renal function decline with a significant mean decrease eGFR from 87.7 to 79 mL/min/1.73 m Conclusions: A significant proportion of patients experience renal function decline following adrenalectomy for PA. Patients with multiple antihypertensive medications, CHD, and lower preoperative potassium and higher eGFR levels are at higher risk. These findings underscore the need for preoperative risk stratification and close postoperative monitoring to optimize long-term renal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.